3SOF

Short-term, I believe TMTA will continue up until RSI 14 hits 70-90 range.

10 MA is continuing up with MACD confirmation.

With such a large gain today, anticipate some profit taking tomorrow - if you want to buy, then wait for any rebounding dip intraday as today's buying pressure volume of 7.3 million shares may continue tomorrow.

Next resistance $0.71.

With such a large drop in price the past year ($2.23 to $0.30), will anyone who bought at higher levels want to sell?

I am anticipating that news of today's rebounding gain of TMTA will continue to bring in buying pressure and any profit taking may be short-lived.

Also, updated after hours trading quotes.

Repost from Yahoo Finance MB thanks to hntraut:

Dead cat bounce or is there actually some good news?

http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_T/threadview?m=me&bn=27380&tid=156122&mid=156122&tof=1&frt=2


Old Transmeta CEO Arthur Swift now working for Arrowhead Research Corp.

http://www.predictwallstreet.com/news/default.aspx?storyID=48898381&symbol=TMTA

"June 18, 2007 (financialwire.net via COMTEX News Network) -- June 18, 2007 (FinancialWire) Arrowhead Research Corp. (NASDAQ: ARWR) has appointed Arthurt L. Swift as chief executive officer and president of its majority-owned subsidiary, Unidym Inc. Unidym, which recently merged with Carbon Nanotechnologies Inc., possesses a foundational patent portfolio that covers nearly every aspect of carbon nanotube manufacturing and processing.

Swift comes to Unidym from Transmeta Corp. (NASDAQ: TMTA), a semiconductor company in the Silicon Valley, where he most recently held the position of president and CEO. Prior to his promotion to CEO, he was senior vice president of marketing. At Transmeta, Swift was instrumental in transforming the company's strategy from selling semiconductor chips to developing and licensing intellectual property, a change that nearly doubled Transmeta's revenue in the first two years after the strategy shift."

Wow, over a million shares within 10 minutes of market open.   

This buying pressure will continue to push the price up even higher.

What a day of trading!

With 11 million shares traded, share price was pushed up to $0.61 before profit taking.  As anticipated, RSI 2 hit above 90 signalling short-term SELL with RSI 14 hitting 70.

Recent gains were very large, and many wanting to lock in profits and the news of old CEO Arthur Swift now working for Arrowhead Research Corp. may have contributed to large intraday fluctuations.  After hours trading is very light.

http://www.predictwallstreet.com/news/default.aspx?storyID=48898381&symbol=TMTA

Next resistance set at $0.69.

If you check VWPT's recent rebound with 3 jumping gains, they were followed by short periods of profit taking before resuming gains.

I believe TMTA will go through similar cycles of large gains and profit taking as 10MA approaches and crosses 50MA.

And if the gains continue, TMTA will also approach the "GOLDEN CROSS" VWPT is about to experience where 50 MA crosses above 200 MA, a very significant trend indicator.

Tuesday's large drop may be due to the issue of Transmeta considering reverse-splitting if Nasdaq listing requirement of keeping share price above $1.00 is not met by September 17, 2007.

This issue certainly is a concern for many.  But as we have seen with Viewpoint, which met the $1.00 listing requirements recently, Transmeta has until September to bring share price back up to $1.00.  Which for us traders may possibly mean that Transmeta will do a lot to raise the share price above $1.00 (How much will the company do?  We'll have to wait and see).

This was a speculative gamble that paid off for Viewpoint traders.  Now the question is will it pay off for Transmeta traders?

If Transmeta is successful in meeting the Nasdaq listing requirements, it would translate to 100% gain for current stock holders.  If not, Transmeta will perform reverse split to raise the share price above $1.00.

I am the gambling type and inclined to take a chance on TMTA, but you make your own decision whether to keep TMTA or not in your portfolio. 


Repost from Yahoo Finance MB thanks to antowanj35:

Transmeta files SCHEDULE 14A on June 19, 2007

http://www.nasdaq.com/asp/quotes_sec.asp?symbol=TMTA&selected=TMTA&page=filings



Also repost from Yahoo Finance MB thanks to tmta_revival about forbes article that talk about pros and cons of reverse splits:

http://www.forbes.com/2002/01/25/0125simons_print.html

"... Of the reverse splits, 84 are still trading that split when their shares were near or below Nasdaq's $1 minimum. (Six were acquired, four went out of business and six split to facilitate such transactions as spinoffs and special dividends.) Contrary to the popular perception, nearly three-quarters have maintained a post-split price above $1.

Of course, merely staying listed isn't investment opportunity. On a pre-split basis, the average price has barely budged from 52 cents. But 39 of the stocks have risen since their reverse splits--up an average 66%, with all but nine of those up at least 20%. (The 45 losers are down 84% on average, but half remain above the listing cutoff).

No clear pattern separates the winners and losers--not even market timing.

... As the examples accompanying the table describe, the opportunity was in ignoring the reverse-split stigma and focusing on each situation individually. Still, playing reverse splits is risky speculation, not investment. Most of the price-performance winners are small companies that haven't established business track records beyond recent reversals of fortune, and now also bear an albatross of per-share losses being amplified due to split-reduced share count.

10 MA continuing to rise and MACD in positive territory, indicating upward momentum.

After recent large gains, short-term profit taking as indicated by RSI 2.

10 MA about to cross 50 MA with RSI flat and MACD in positive territory.

Anticipate continued gains.

10 MA crossing through 50 MA with HUGE (22.2 million shares!!!) volume increase.

Anticipate continued gain.

TMTA has failed to meet NASDAQ Global Market continued listing requirement(s).
• Transmeta To Hold Annual Meeting of Stockholders on July 31, 2007

Bouncing off a 50% Fibonacci retracement.

52wk Range: 0.28 - 1.41
Volume: 2,797,024
Avg Vol (3m): 3,442,520

Technicals
RS Rating: 96 

Fundamentals
Key Data:
Market Cap (M): $131.96 
P/E Ratio: 17.08 
PEG Ratio: N/A 
Next Earnings: 08/07/2007
Last Analyst Rating: Strong Buy

Up 230%. Check it out;

8:03AM Transmeta announces settlement of patent litigation, technology transfer and license agreement with Intel (TMTA) 4.18 : Co announces that it has reached an agreement with Intel to settle all claims between them and to license the TMTA patent portfolio to Intel (INTC) for use in current and future Intel products. The agreement will grant INTC a perpetual non-exclusive license to all TMTA patents and patent applications, including any patent rights later acquired by TMTA, now existing or as may be filed during the next ten years. TMTA will also transfer technology and grant to Intel a non-exclusive license to TMTA's LongRun and LongRun2 technologies and future improvements. Under the agreement, INTC will covenant not to sue TMTA for the development and licensing to third parties of TMTA's LongRun and LongRun2 technologies. The agreement provides for Intel to make an initial $150 mln payment to TMTA as well as to pay TMTA an annual license fee of $20 mln for each of the next five years. The agreement also provides for the parties to dismiss their pending patent litigation with prejudice and for a mutual general release of all claims of any type between the parties.

Up 230%. Check it out;

8:03AM Transmeta announces settlement of patent litigation, technology transfer and license agreement with Intel (TMTA) 4.18 : Co announces that it has reached an agreement with Intel to settle all claims between them and to license the TMTA patent portfolio to Intel (INTC) for use in current and future Intel products. The agreement will grant INTC a perpetual non-exclusive license to all TMTA patents and patent applications, including any patent rights later acquired by TMTA, now existing or as may be filed during the next ten years. TMTA will also transfer technology and grant to Intel a non-exclusive license to TMTA's LongRun and LongRun2 technologies and future improvements. Under the agreement, INTC will covenant not to sue TMTA for the development and licensing to third parties of TMTA's LongRun and LongRun2 technologies. The agreement provides for Intel to make an initial $150 mln payment to TMTA as well as to pay TMTA an annual license fee of $20 mln for each of the next five years. The agreement also provides for the parties to dismiss their pending patent litigation with prejudice and for a mutual general release of all claims of any type between the parties.

TMTA looks great, just got a pop...hoping to see $20 soon on it